ARYAN AI opens partnering for target-discovery and co-development projectsPlaceholder
We are inviting academic groups, biotech companies and pharmaceutical partners to collaborate on target discovery, molecule design and joint programmes.
ARYAN AI is opening a limited number of partnering slots for the coming year. Collaborations can range from a focused target-discovery project in a defined disease area to full co-development of a programme.
Partners gain access to our evidence engine, generative design and wet-lab validation, with clear data-governance terms agreed before any data is exchanged.
Interested organisations can reach the partnering team through the contact page.